Document Detail


Prophylactic use of antimalarials during pregnancy.
MedLine Citation:
PMID:  22084457     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
QUESTION: Some of my pregnant patients wish to travel to malaria-endemic regions. Are there medications that can be used safely during pregnancy for malaria prophylaxis?
ANSWER: Pregnant women should avoid travel to malaria-endemic areas if possible. However, if travel cannot be avoided, measures to prevent mosquito bites, along with an effective chemoprophylaxis regimen, should be implemented. Chloroquine or hydroxychloroquine are considered safe to use in all trimesters of pregnancy. Mefloquine is the agent of choice for chloroquine-resistant areas, and evidence suggests it is not associated with an increased risk to the fetus. Although the atovaquone-proguanil drug combination is not currently recommended for use during pregnancy, limited data suggest that it is not harmful to the fetus. Doxycycline and primaquine are not recommended during pregnancy.
Authors:
Marie-Hélène Irvine; Adrienne Einarson; Pina Bozzo
Related Documents :
22052087 - Transport of nanoparticles through the placental barrier.
14617457 - Acute spinal cord injury in pregnancy: an illustrative case and literature review.
24547967 - The role of regulatory t cell (treg) subsets in gestational diabetes mellitus.
18046077 - Management of pregnancy in adolescence complicated by acute lymphoblastic leukemia.
7877067 - Does a paracervical block with bupivacaine change vascular resistance in uterine and um...
904817 - Fetal monitoring: psychologic consequences and management recommendations.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian family physician Médecin de famille canadien     Volume:  57     ISSN:  1715-5258     ISO Abbreviation:  Can Fam Physician     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-15     Completed Date:  2012-04-10     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  0120300     Medline TA:  Can Fam Physician     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1279-81     Citation Subset:  IM    
Affiliation:
Faculty of Pharmacy, University of Toronto, Ont.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antimalarials / adverse effects,  therapeutic use*
Atovaquone / adverse effects,  therapeutic use
Chemoprevention
Chloroquine / adverse effects,  therapeutic use
Doxycycline / adverse effects,  therapeutic use
Drug Combinations
Female
Humans
Hydroxychloroquine / adverse effects,  therapeutic use
Malaria / prevention & control*
Mefloquine / adverse effects,  therapeutic use
Pregnancy
Pregnancy Complications, Parasitic / prevention & control*
Primaquine / adverse effects,  therapeutic use
Proguanil / adverse effects,  therapeutic use
Travel
Chemical
Reg. No./Substance:
0/Antimalarials; 0/Drug Combinations; 0/atovaquone, proguanil drug combination; 118-42-3/Hydroxychloroquine; 500-92-5/Proguanil; 53230-10-7/Mefloquine; 54-05-7/Chloroquine; 564-25-0/Doxycycline; 90-34-6/Primaquine; 94015-53-9/Atovaquone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summar...
Next Document:  Update on acute otitis media in children younger than 2 years of age.